comparemela.com

Raphael Rafi Hofstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United statesIsrael generalCelgene bristol myers squibbRodd leeds david waldmanScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incCrescendo communicationsWeizmann institute of scienceExchange commissionCompany formDelaware court

Scopus BioPharma Announces Biotechnology Industry Leader

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma.

United statesIsrael generalCelgene bristol myers squibbScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incWeizmann institute of scienceDelaware courtHebrew university of jerusalemLife sciencesCorporation lawFibrocor therapeutics

Scopus BioPharma Inc (SCPS) Appoints Raphael Hofstein to its Board

Scopus BioPharma Inc (SCPS) Appoints Raphael Hofstein to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIsrael generalCelgene bristol myers squibbScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incWeizmann institute of scienceDelaware courtHebrew university of jerusalemLife sciencesCorporation lawFibrocor therapeutics

DR MORRIS C LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC BOARD OF DIRECTORS

/PRNewswire/ Dr. Morris C. Laster ("Dr. Laster"), who, together with other proxy participants, beneficially owns 6,006,000 shares of common stock, par value.

Israel generalMordechai saar hachamJoshua levineRaphael rafi hofsteinDavids battlemanCompany for the annual meetingScopus biopharma incCompany board of directorsFirst coast results incCitrin cooperman companyScopus biopharmaCoast resultsAnnual meetingCitrin coopermanChen lasterGabriella laster

DR MORRIS C LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC BOARD OF DIRECTORS

/PRNewswire/ Dr. Morris C. Laster ("Dr. Laster"), who, together with other proxy participants, beneficially owns 6,006,000 shares of common stock, par value.

Israel generalMordechai saar hachamJoshua levineRaphael rafi hofsteinDavids battlemanCompany for the annual meetingScopus biopharma incCompany board of directorsFirst coast results incCitrin cooperman companyScopus biopharmaCoast resultsAnnual meetingCitrin coopermanChen lasterGabriella laster

vimarsana © 2020. All Rights Reserved.